Related Experiment Videos
The assessment of treatment outcomes in metastatic prostate cancer: changing endpoints
1Walter Reed Army Medical Center, Washington, District of Columbia 20307-5001, USA.
European Journal of Cancer (Oxford, England : 1990)
|April 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.
Prostate cancer and prostatic diseases·2012
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
Prostate cancer and prostatic diseases·2010
ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
Prostate cancer and prostatic diseases·2010
Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2-ERG fusion status.
Prostate cancer and prostatic diseases·2009
Towards a more proportionate EU framework for low-intervention clinical trials: Lessons from the UK and Switzerland.
European journal of cancer (Oxford, England : 1990)·2026
Recent trends in childhood, teenage and young adult cancer incidence in England (2001-2020).
European journal of cancer (Oxford, England : 1990)·2026
A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study.
European journal of cancer (Oxford, England : 1990)·2026
Molecular characteristics and clinical outcomes of ERBB2-activating mutation-positive non-small cell lung cancer: A Japanese nationwide real-world cohort.
European journal of cancer (Oxford, England : 1990)·2026
Timing of first-line palliative systemic therapy in metastatic esophagogastric adenocarcinoma: A population-based analysis & target trial emulation.
European journal of cancer (Oxford, England : 1990)·2026
Liquid biopsy tumour fraction, total tumour volume, and automated whole-body CT body composition for survival stratification in metastatic cancer: A temporally validated pan-cancer cohort study.
European journal of cancer (Oxford, England : 1990)·2026
MAGEA6 Promoted Gastric Cancer Progression by Activating Mitophagy.
Molecular carcinogenesis·2026
Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials.
Current medical research and opinion·2026
Prognostic Value of Primary Tumor and Immune Organ Metabolic Parameters Derived from Pretreatment 18F-FDG PET/CT in Gastric Adenocarcinoma: A Retrospective Survival Analysis.
Molecular imaging and radionuclide therapy·2026
Cell-based polygenic risk scores predict clinical progression and prioritize network-based therapeutic targets in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association·2026